SCHEMBL6166326

SCHEMBL6166326

[c]1conc1Cc1cccnc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CHRNA7 P36544 1/20 0.41
MMP2 P08253 1/20 0.41
CHRNB2 P17787 3/20 0.40
CHRNA4 P43681 3/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
TBXAS1 P24557 2/20 0.39
CYP2A6 P11509 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL727185 0.73 CYP1A2 (0.62) HRH4HRH3CYP1A2CYP2D6CHRNA7
SCHEMBL27588640 0.72 MAOB (0.41) CYP11B1CYP11B2
SCHEMBL6167380 0.71 CYP11B1 (0.44) HRH4HRH3CYP1A2CYP2D6CHRNA7
SCHEMBL6166905 0.68 HRH3 (0.43) HRH4HRH3TDP1L3MBTL1
SCHEMBL29995759 0.68 CYP11B1 (0.65) HRH4HRH3CYP1A2CYP2D6CHRNA7
SCHEMBL14257669 0.68 CYP1A2 (0.56) HRH4HRH3CYP1A2CYP2D6CHRNA7
SCHEMBL177863 0.68 CYP11B1 (0.65) HRH4HRH3CYP1A2CYP2D6CHRNA7
SCHEMBL24769738 0.66 CYP1A2 (0.54) HRH4HRH3CYP1A2CYP2D6CHRNA7
Ammonia Solution, Strong SCHEMBL5999508 0.66 CYP11B1 (0.62) HRH4HRH3CYP1A2CYP2D6CHRNA7
SCHEMBL16996646 0.66 MMP2 (0.65) HRH4HRH3CYP1A2CYP2D6CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417177-A4 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-10-19 EP disclosed
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 CN disclosed
EP-1417177-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003007883-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-01-30 WO disclosed
CN-1297442-A 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents DU PONT PHARM CO (US) 2001-05-30 CN disclosed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 EP disclosed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 WO disclosed